Research

Esser will work with scientists to accelerate the development of new medicines and treatments for illnesses like cancer and Alzheimer's.

One of Esser's responsibilities will be to foster an "ecosystem of innovation" that will attract biotechnology and pharmaceutical companies to Central Virginia and the greater Commonwealth.

One of Esser's responsibilities will be to foster an "ecosystem of innovation" that will attract biotechnology and pharmaceutical companies to Central Virginia and the greater Commonwealth.

A big, bold vision for a high-impact, future-ready regional economy is in development. The project is supported by a broad coalition of stakeholders, including local government & economic development, higher education & research institutions…

A big, bold vision for a high-impact, future-ready regional economy is in development. The project is supported by a broad coalition of stakeholders, including local government & economic development, higher education & research institutions…

The Commonwealth BioAccelerator officially opened its doors, transforming 6,500 square feet of cutting-edge lab space into a launchpad for Virginia's most promising biotech ventures.

UVA-affiliated startup BrightSpec launched the world's first commercial Molecular Rotational Resonance (MRR) instruments in 50 years. The team received a PittCon Today Excellence Award in recognition of their innovation and the impact of their new…

UVA-affiliated startup BrightSpec launched the world's first commercial Molecular Rotational Resonance (MRR) instruments in 50 years. The team received a PittCon Today Excellence Award in recognition of their innovation and the impact of their new…

CvilleBioHub, a regional, industry-led organization, received a $4.3 million GO Virginia award and is partnering with UVA to establish the region's first laboratory accelerator at North Fork.

Starting from the campus of the University of Virginia, AgroSpheres has created a comprehensive biomodality platform, injecting strong momentum into the sustainable development of global agriculture.

As part of the new institute, UVA's Biocomplexity Institute (BI) is contributing innovative AI research and solutions that will bolster efforts to detect illicit financial activity and address vulnerabilities within global supply chains.

A statewide biopharma boom is fueled by talent emerging from Virginia's universities, which provide a steady pipeline of specialized labor.